Amgen Inc.

AMGN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Assets
Cash & Equivalents $3.80B $3.24B $4.14B $3.73B $3.81B $3.26B $6.95B $3.29B
Accounts Receivable $3.24B $3.17B $3.00B $2.55B $2.70B $2.52B $2.90B $2.34B
Inventory $2.83B $2.75B $2.44B $2.65B $3.02B $2.74B $2.48B $2.02B
Total Current Assets $49.48B $46.01B $38.52B $34.71B $27.37B $31.21B $27.59B $23.13B
Property, Plant & Equipment $4.99B $4.96B $4.91B $5.22B $5.35B $5.33B $5.42B $5.52B
Goodwill $14.76B $14.76B $14.75B $14.79B $14.97B $12.66B $11.75B $11.33B
Intangible Assets (Excl. Goodwill) $8.61B $10.28B $11.64B $12.69B $13.26B $3.97B $2.58B $2.23B
Total Assets $79.95B $77.63B $71.45B $69.01B $66.13B $54.30B $48.87B $43.49B
Liabilities
Accounts Payable $1.35B $917.0M $965.0M $995.0M $787.0M $905.0M $642.0M $716.0M
Total Current Liabilities $9.02B $11.20B $8.66B $7.01B $7.95B $8.19B $5.75B $6.57B
Long-Term Debt $34.19B $30.19B $29.18B $30.22B $29.62B $26.53B $21.43B $10.87B
Total Liabilities $54.71B $47.75B $43.37B $43.23B $44.03B $35.24B $29.84B $19.54B
Stockholders' Equity
Retained Earnings $-5.07B $-438.0M $-2.09B $-4.62B $-7.63B $-10.42B $-8.92B $-3.51B
Total Stockholders' Equity $25.24B $29.88B $28.08B $25.78B $22.10B $19.06B $19.03B $23.94B
← Newer Page 2 of 3 Older →